Tocilizumab Withdrawal Post Remission in Still ' s Disease Tocilizumab Withdrawal Post Remission in Still ' s Disease

Longer tocilizumab administration intervals and lower prednisolone doses seemed pivotal for successful tocilizumab withdrawal while maintaining remission in patients with AOSD.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology Clinical Summary Source Type: news